Knight Therapeutics (04K.F) Q1 2025 Earnings

20MarConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.03
0.01
0.04
0.07

Details

Expected EPS
0.011445793205535001
Actual EPS
0.07040414095
Surprise EPS
0.06
Surprise Percent
+515.11%

Description

Knight Therapeutics (04K.F) has reported earnings of 0.07040414095 per share for Q1 2025.

0 Comments

Share your thoughts